2017
DOI: 10.3748/wjg.v23.i3.505
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer

Abstract: AIMTo evaluate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with colorectal cancer (CRC).METHODSBetween April 1996 and December 2010, medical records from a total of 1868 patients with CRC were retrospectively reviewed. The values of simple inflammatory markers including NLR and PLR in predicting the long-term outcomes of these patients were evaluated using Kaplan-Meier curves and Cox regression models.RESULTSThe median follow-up duration w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
54
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(60 citation statements)
references
References 38 publications
(42 reference statements)
4
54
0
Order By: Relevance
“…Similar to elevated platelet count, high PLR has been found to be associated with worse survival in a variety of solid (hepatocellular, ovarian, cervix, colorectal, bile duct, breast, lung, renal cell, gastric, prostate, and oesophageal) tumours [30][31][32][33][34][35][36][37][38][39][40]. Moreover, several studies confirmed the relationship between elevated NLR and a worse prognosis in patients with malignant oesophageal [41], colorectal [42,43], pancreas [44,45], prostate [46,47], hepatic [48,49], bile duct [50], breast [51], gastric [52,53], cutaneous melanocytic [54], thyroid medullary [55], and lung [56] tumours.…”
Section: Discussionmentioning
confidence: 98%
“…Similar to elevated platelet count, high PLR has been found to be associated with worse survival in a variety of solid (hepatocellular, ovarian, cervix, colorectal, bile duct, breast, lung, renal cell, gastric, prostate, and oesophageal) tumours [30][31][32][33][34][35][36][37][38][39][40]. Moreover, several studies confirmed the relationship between elevated NLR and a worse prognosis in patients with malignant oesophageal [41], colorectal [42,43], pancreas [44,45], prostate [46,47], hepatic [48,49], bile duct [50], breast [51], gastric [52,53], cutaneous melanocytic [54], thyroid medullary [55], and lung [56] tumours.…”
Section: Discussionmentioning
confidence: 98%
“…Inflammation and tumor growth are dependent factors, and increasing numbers of studies have elucidated the role of systemic inflammatory response mediators in various solid cancers [13,14]. Among them, GC is one of the popular foci of these investigations that evaluated cancerrelated inflammation and possible predictors in the preoperative period [6][7][8].…”
Section: Discussionmentioning
confidence: 99%
“…Various studies have recommended different cutoff points for the NLR (ranging between 3 and 5) and PLR (ranging between 0.66 and 0.44) [3,7,13]. In the literature, different calculations have been proposed for the PLR, and this study used a relatively less common method (as described in the study by Inaoka et al) [3].…”
Section: Discussionmentioning
confidence: 99%
“…Systemic inflammation has been proved to play an important part in the tumorigenesis and tumor progression because of inflammatory mediators having the ability of accelerating vascular permeability, facilitating tumor cell infiltration via blood and lymphatic vessels [4][5][6]. Some biomarkers of peripheral blood examination, such as platelet to lymphocyte ratio (PLR) [7,8], neutrophil to lymphocyte ratio (NLR) [9][10][11][12], the Glasgow prognostic score (GPS) [13], prognostic nutritional index (PNI) [14], have been shown to reflect the degree of systemic inflammation. This theory has led to widely investigate peripheral blood examination in the hope of developing reliable, reproducible and low-cost prognostic factor.…”
Section: Introductionmentioning
confidence: 99%